ILMN's Connected Multiomics, launched after early user input, advances precision health research and may boost the stock.
The field of cancer immunology has witnessed dramatic progress with the advent of immunotherapies targeting the tumor immune microenvironment (TIME).
Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...
The partners are launching ImmuneScape, a multiomics program using spatial and single-cell sequencing to study immune drivers ...
Research led by the SickKids Research Institute in Toronto and the University of Pennsylvania, has found that immune-related ...
The largest single cell perturbation dataset to-date will be generated and released open source in a new team effort.
Alzheimer’s disease (AD) and related dementias present significant challenges in therapeutic development, particularly within ...
Learn how AI is transforming predictions of drug-induced liver injury and aiding drug development for safer therapeutics.